Efficacy and Safety of <i>Saccharomyces boulardii</i> in the 14‐day Triple Anti‐<i>Helicobacter pylori</i> Therapy: A Prospective Randomized Placebo‐Controlled Double‐Blind Study

Abstract

S. boulardii improved anti-H. pylori antibiotherapy-associated diarrhea, epigastric discomfort, and treatment tolerability. In addition, S. boulardii supplement decreased post-treatment dyspepsia symptoms independent of H. pylori status. However, S. boulardii had no significant affect on the rate of H. pylori eradication.